Mountain Group Capital

MiNDERA Corporation specializes in the development of non-invasive molecular testing devices aimed at diagnosing skin cancer and other skin diseases. The company has created a micro-needle array patch that allows for pain-free and minimally invasive extraction of biomarkers, such as RNA, DNA, and proteins, from the skin without the need for traditional biopsies. Additionally, MiNDERA develops specialized patches for whole transcriptome extraction and skin microbiome extraction, which are designed for research applications. Founded in 2013, MiNDERA is headquartered in Palo Alto, California.

PinkDx is a biotechnology company specializing in women's health. It develops molecular tests to improve diagnostic outcomes for women with vague gynecological cancer symptoms, offering alternatives to invasive procedures. This enables more comfortable and efficient resolution of health concerns, providing timely and positive impacts on patients' lives.

Founded in 2021, Circular Genomics specializes in harnessing circular RNA as innovative biomarkers for precision medicine. The company focuses on improving diagnosis and treatment of neurological and psychiatric conditions by offering evidence-based diagnostic assays.

Airvet is a telemedicine platform for pet care that connects pet owners with veterinarians for virtual appointments and real-time communication. The service enables general health checks, medical and behavioral questions, and follow-ups through live video, audio, and chat, improving access to veterinary care and strengthening the continuity of care between clinics and clients. Founded in 2018, Airvet is based in California, with a focus on delivering convenient, affordable veterinary consultations and supporting clinics in expanding patient engagement and revenue opportunities.

Vytelle, LLC is a biotechnology company focused on enhancing cattle genetics through advanced reproductive technology. Founded in 2015 and based in Hermiston, Oregon, Vytelle offers ovum pick-up and embryo production services specifically tailored for beef and dairy cows. The company employs a proprietary culture system for embryo development that does not utilize fetal calf serum, enabling the production of freezable embryos. This innovative approach allows commercial cattle producers to achieve sustainable genetic advancements over multiple generations. Vytelle collaborates with industry specialists and licensed veterinarians to optimize herd management and reproductive outcomes, positioning itself as a leader in precision livestock solutions.

Silicon Ranch is a developer, owner, and operator of utility-scale solar energy projects in the United States. The company builds and operates solar facilities, including installations in Social Circle, Georgia, and at Volkswagen’s Chattanooga manufacturing facility in Tennessee. It also runs a regional energy-training center that provides classroom and on-the-job training in solar installation, maintenance, and weatherization, and assists clients with project development and financing options. Silicon Ranch emphasizes long-term ownership of its projects and collaborates with utilities and a range of commercial and industrial customers to deliver cost-effective, reliable solar energy. Founded in 2010 and based in Nashville, Tennessee, the company focuses on delivering sustainable energy resources and community and economic development through its solar portfolio.

AngelEye Health is a developer of a tele-engagement platform designed to integrate parents into the care team during their child's stay in neonatal intensive care units (NICUs) and pediatric units. The company offers a comprehensive, HIPAA-compliant solution that includes bedside cameras, patient communication tools, feeding management systems, and targeted educational resources. These services enhance care team workflows and provide families with improved access to their child's treatment plans and progress through any connected device. By fostering meaningful care experiences, AngelEye Health aims to improve family satisfaction, enhance care delivery efficiency, and ultimately elevate the quality of care for patients.

Verility develops fertility products for livestock producers and breeders. Their technology enables accurate, simple, and cost-effective analysis of animal semen samples at the point-of-care, improving reproductive performance and enhancing food sustainability.

TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. It develops AI- and ML-powered platforms to improve management decisions, including detecting the sex of chicks at the hatchery to enable gender-specific feeding strategies and optimizing farm performance. It is also developing vaccination solutions that detect, target, and deliver vaccines to individual chicks, enhancing vaccination accuracy, immune response, and flock health. Through these technologies, TARGAN aims to advance animal welfare, reduce disease risk, and support more efficient production across animal farming sectors.

Silicon Ranch is a developer, owner, and operator of utility-scale solar energy projects in the United States. The company builds and operates solar facilities, including installations in Social Circle, Georgia, and at Volkswagen’s Chattanooga manufacturing facility in Tennessee. It also runs a regional energy-training center that provides classroom and on-the-job training in solar installation, maintenance, and weatherization, and assists clients with project development and financing options. Silicon Ranch emphasizes long-term ownership of its projects and collaborates with utilities and a range of commercial and industrial customers to deliver cost-effective, reliable solar energy. Founded in 2010 and based in Nashville, Tennessee, the company focuses on delivering sustainable energy resources and community and economic development through its solar portfolio.

Founded in 2021, Circular Genomics specializes in harnessing circular RNA as innovative biomarkers for precision medicine. The company focuses on improving diagnosis and treatment of neurological and psychiatric conditions by offering evidence-based diagnostic assays.

TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. It develops AI- and ML-powered platforms to improve management decisions, including detecting the sex of chicks at the hatchery to enable gender-specific feeding strategies and optimizing farm performance. It is also developing vaccination solutions that detect, target, and deliver vaccines to individual chicks, enhancing vaccination accuracy, immune response, and flock health. Through these technologies, TARGAN aims to advance animal welfare, reduce disease risk, and support more efficient production across animal farming sectors.

MiNDERA Corporation specializes in the development of non-invasive molecular testing devices aimed at diagnosing skin cancer and other skin diseases. The company has created a micro-needle array patch that allows for pain-free and minimally invasive extraction of biomarkers, such as RNA, DNA, and proteins, from the skin without the need for traditional biopsies. Additionally, MiNDERA develops specialized patches for whole transcriptome extraction and skin microbiome extraction, which are designed for research applications. Founded in 2013, MiNDERA is headquartered in Palo Alto, California.

Advanced Animal Diagnostics, Inc. specializes in the research, development, and commercialization of on-farm diagnostic tools aimed at the early detection of subclinical mastitis in dairy cows. Founded in 2001 and based in Durham, North Carolina, the company offers innovative products such as the QScout Farm Lab, an analyzer system that detects infections before visible symptoms occur, and the QScout Milk Leukocyte Differential rapid test, which identifies and differentiates leukocytes in milk to facilitate early mastitis detection. Additionally, Advanced Animal Diagnostics provides the QuickSmear slide for animal research and the SCC+ System for timely mastitis diagnosis. The company's solutions focus on enhancing the management of disease states and improving the reproductive, nutritional, and overall health of production animals, serving veterinarians and livestock producers to promote healthier and more productive animal care.

Silicon Ranch is a developer, owner, and operator of utility-scale solar energy projects in the United States. The company builds and operates solar facilities, including installations in Social Circle, Georgia, and at Volkswagen’s Chattanooga manufacturing facility in Tennessee. It also runs a regional energy-training center that provides classroom and on-the-job training in solar installation, maintenance, and weatherization, and assists clients with project development and financing options. Silicon Ranch emphasizes long-term ownership of its projects and collaborates with utilities and a range of commercial and industrial customers to deliver cost-effective, reliable solar energy. Founded in 2010 and based in Nashville, Tennessee, the company focuses on delivering sustainable energy resources and community and economic development through its solar portfolio.

AN2 Therapeutics is a biopharmaceutical company dedicated to researching, developing, and commercializing innovative medicines targeting infectious diseases. Established in 2017, the company focuses on advancing a clinical-stage antibacterial compound and has a strategic partnership with Brii Biosciences.

TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. It develops AI- and ML-powered platforms to improve management decisions, including detecting the sex of chicks at the hatchery to enable gender-specific feeding strategies and optimizing farm performance. It is also developing vaccination solutions that detect, target, and deliver vaccines to individual chicks, enhancing vaccination accuracy, immune response, and flock health. Through these technologies, TARGAN aims to advance animal welfare, reduce disease risk, and support more efficient production across animal farming sectors.

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiopulmonary diseases. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor, intended to manage uncontrolled bleeding events or urgent surgeries. PhaseBio is also developing PB1046 for pulmonary arterial hypertension and PB6440 for resistant hypertension.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,

Boragen Inc. is a biotechnology company specializing in the design and development of multifunctional small molecule boron solutions for crop protection, animal health, and human health applications. Its pipeline includes products like BAG8, a boron-based multisite fungicide for crops, and BN2266, an innovative MOA crop protection fungicide targeting mRNA processing.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 clinical trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. Additionally, G1 is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company collaborates with Quantum Leap Healthcare Collaborative to explore trilaciclib's potential in neoadjuvant treatment for locally advanced breast cancer. Founded in 2008, G1 Therapeutics aims to address unmet medical needs in oncology by enhancing the effectiveness of existing cancer therapies.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

splitsecnd is a developer of a unique portable plug-in vehicle connectivity device that enhances driver safety by providing automatic crash response and roadside assistance. Designed to be easily installed in any vehicle through the 12V lighter outlet, the device utilizes airbag sensor technology to detect accidents and immediately alert emergency personnel. In addition to its automatic features, splitsecnd allows for manual activation during emergencies. The device also offers GPS capabilities and comprehensive trip analytics, enabling users to track routes, promote safe driving behaviors, and locate parked vehicles. This versatile solution is particularly beneficial for seniors, teens, and drivers of all ages, ensuring support on the road regardless of the circumstances or vehicle type, all without the need for a cell phone.

Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.

Myomo designs, develops, and produces myoelectric orthotics for individuals with neuromuscular disorders, enabling functional activities of daily living. Its flagship product, MyoPro, is a myoelectric-controlled upper limb brace orthosis used to support weak or paralyzed arms. Myomo serves medical professionals, patients, and caregivers in the United States.

Contego Medical is a medical device company that develops integrated embolic protection technologies for cardiovascular and endovascular procedures. Its product line includes angioplasty balloons and stent delivery catheters that combine treatment and embolic protection, enabling safer interventions in carotid, renal, SVG, and coronary arteries. The company holds FDA clearance for the Paladin Carotid PTA Balloon System with Integrated Embolic Protection, the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection, and the Excipio SV Thrombectomy Device. Founded in 2005, Contego Medical is headquartered in Raleigh, North Carolina, with an additional office in Curitiba, Brazil.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 clinical trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. Additionally, G1 is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company collaborates with Quantum Leap Healthcare Collaborative to explore trilaciclib's potential in neoadjuvant treatment for locally advanced breast cancer. Founded in 2008, G1 Therapeutics aims to address unmet medical needs in oncology by enhancing the effectiveness of existing cancer therapies.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

Lineagen, Inc. is a genetic diagnostic company specializing in genetic testing and clinical information services for neurodevelopmental disorders, particularly autism. Founded in 2002 and based in Salt Lake City, Utah, Lineagen offers a range of services including FirstStepDx PLUS, a chromosomal microarray platform designed to identify genomic changes related to autism and other neurodevelopmental conditions, and NextStepDx PLUS, a genetic sequencing test that detects subtle genomic variations. The company also provides M-CHAT.org, an online tool for developmental assessment by healthcare professionals and parents. Lineagen's commitment to improving health outcomes for individuals affected by autism and similar disorders is supported by its access to the Utah Population Database, a resource that enhances its research capabilities in identifying genetic causes and diagnostic pathways for complex diseases. As of August 2020, Lineagen operates as a subsidiary of Bionano Genomics, Inc.

Clearside Biomedical is a biopharmaceutical company focused on developing treatments for serious eye diseases. It specializes in delivering drugs directly to specific compartments of the eye using its proprietary suprachoroidal injection platform, aiming to restore and preserve vision.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

Castle Biosciences is a molecular diagnostics company headquartered in Friendswood, Texas, that develops and commercializes gene‑expression‑profile tests for dermatologic cancers, uveal melanoma, and Barrett’s esophagus. Its flagship product, DecisionDx‑Melanoma, predicts the risk of metastasis in stage I and II cutaneous melanoma by analyzing 31 tumor‑derived genes. The company also offers DecisionDx‑UM for uveal melanoma, DecisionDx‑SCC for cutaneous squamous cell carcinoma, MyPath Melanoma for diagnostically challenging melanocytic lesions, and TissueCypher for predicting progression of high‑grade dysplasia in Barrett’s esophagus. Tests are delivered to physicians, physician assistants, and nurse practitioners to support personalized treatment decisions. Founded in 2007, Castle Biosciences focuses on providing clinically actionable genomic information to improve cancer diagnosis and management.

InvisionHeart is a company focused on enhancing cardiac care through innovative technology. It has developed a mobile electrocardiograph system that captures vital cardiac data, allowing a network of healthcare professionals—including physicians, nurses, and technicians—to securely access and annotate patient electrocardiogram tracings. The technology was initially created by a collaborative team of physicians and engineers at Vanderbilt University, addressing practical clinical challenges faced in heart care. With a strong leadership team and a dedicated clinical advisory board, InvisionHeart aims to improve the quality of care for heart patients, ensuring that essential cardiac information is readily available to healthcare providers regardless of their location.

NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.

NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. The company is advancing several key drug candidates, including trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor currently in Phase 1b/2 clinical trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. Additionally, G1 is developing lerociclib, an oral CDK4/6 inhibitor in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer, as well as rintodestrant, an oral selective estrogen receptor degrader in Phase I/2 trials. The company collaborates with Quantum Leap Healthcare Collaborative to explore trilaciclib's potential in neoadjuvant treatment for locally advanced breast cancer. Founded in 2008, G1 Therapeutics aims to address unmet medical needs in oncology by enhancing the effectiveness of existing cancer therapies.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Best ABT Molecular Imaging, Inc. is a medical imaging company specializing in the design, manufacture, marketing, and servicing of biomarker generator systems and related accessories. The company offers the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, ensuring immediate availability and quality through comprehensive control tests for each dose generated. Founded by Ron and Lynda Nutt in 2006, Best ABT leverages its expertise in molecular imaging, which has roots dating back to the early 1980s. The company's innovative technology includes a self-shielded mini-cyclotron for producing the positron-emitting F-18 isotope and a microchemistry system for labeling specific molecules. Headquartered in Louisville, Tennessee, Best ABT distributes its products globally through a network of sales and service distributors, facilitating the expansion of PET imaging capabilities worldwide.

SwingPal, LLC is a company based in Franklin, Tennessee, that operates an innovative online platform for learning golf. Established in 2010, the platform connects golfers with instructors through web and mobile access. Users can record their swings using a smartphone and upload the videos to their SwingPal accounts. They then receive detailed feedback, including annotated video and audio analysis from golf professionals, along with additional instructional content. This service is designed to help golfers improve their skills and modify their gameplay effectively.

StreamWeaver is a software company based in Nashville, Tennessee. The company specializes in developing innovative technology solutions aimed at enhancing collaboration and productivity. Its flagship product is a multi-angle mobile video application that facilitates seamless connections between users, allowing them to record videos together and automatically generating split-screen content. Additionally, StreamWeaver offers a technology platform that integrates and streams data from popular IT tools in near real-time, utilizing event-driven automation to enhance operational efficiency. This platform enables organizations to reduce integration costs while achieving greater observability across their IT operations.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

American Hometown Media, Inc. is a digital media company based in Nashville, Tennessee, specializing in the publishing of content that highlights American home cooks. Founded in 2011, the company operates an internet platform that syndicates editorial content to community newspapers, magazines, and other media outlets across the country. It focuses on celebrating the culinary contributions of everyday individuals, positioning them as the central figures in its offerings. One of its key features is Just A Pinch Recipes, a digital recipe and coupon social network aimed at home cooks. Additionally, American Hometown Media provides Just A Pinch Syndicated Media, which delivers content related to recipes and the cultural heritage of America's hometowns. By leveraging traditional publishing roots while embracing digital technology, the company effectively connects with a broad audience, reaching around two million households weekly through its syndicated columns.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

SwingPal, LLC is a company based in Franklin, Tennessee, that operates an innovative online platform for learning golf. Established in 2010, the platform connects golfers with instructors through web and mobile access. Users can record their swings using a smartphone and upload the videos to their SwingPal accounts. They then receive detailed feedback, including annotated video and audio analysis from golf professionals, along with additional instructional content. This service is designed to help golfers improve their skills and modify their gameplay effectively.

StreamWeaver is a software company based in Nashville, Tennessee. The company specializes in developing innovative technology solutions aimed at enhancing collaboration and productivity. Its flagship product is a multi-angle mobile video application that facilitates seamless connections between users, allowing them to record videos together and automatically generating split-screen content. Additionally, StreamWeaver offers a technology platform that integrates and streams data from popular IT tools in near real-time, utilizing event-driven automation to enhance operational efficiency. This platform enables organizations to reduce integration costs while achieving greater observability across their IT operations.

Best ABT Molecular Imaging, Inc. is a medical imaging company specializing in the design, manufacture, marketing, and servicing of biomarker generator systems and related accessories. The company offers the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, ensuring immediate availability and quality through comprehensive control tests for each dose generated. Founded by Ron and Lynda Nutt in 2006, Best ABT leverages its expertise in molecular imaging, which has roots dating back to the early 1980s. The company's innovative technology includes a self-shielded mini-cyclotron for producing the positron-emitting F-18 isotope and a microchemistry system for labeling specific molecules. Headquartered in Louisville, Tennessee, Best ABT distributes its products globally through a network of sales and service distributors, facilitating the expansion of PET imaging capabilities worldwide.

StreamWeaver is a software company based in Nashville, Tennessee. The company specializes in developing innovative technology solutions aimed at enhancing collaboration and productivity. Its flagship product is a multi-angle mobile video application that facilitates seamless connections between users, allowing them to record videos together and automatically generating split-screen content. Additionally, StreamWeaver offers a technology platform that integrates and streams data from popular IT tools in near real-time, utilizing event-driven automation to enhance operational efficiency. This platform enables organizations to reduce integration costs while achieving greater observability across their IT operations.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

SwingPal, LLC is a company based in Franklin, Tennessee, that operates an innovative online platform for learning golf. Established in 2010, the platform connects golfers with instructors through web and mobile access. Users can record their swings using a smartphone and upload the videos to their SwingPal accounts. They then receive detailed feedback, including annotated video and audio analysis from golf professionals, along with additional instructional content. This service is designed to help golfers improve their skills and modify their gameplay effectively.

NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.

MedCenterDisplay, LLC specializes in digital patient engagement solutions for hospitals and clinics throughout the United States. Based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, social media management, and application development. These solutions are designed to enhance patient satisfaction, reduce avoidable readmissions, and improve healthcare-related metrics such as HCAHPS scores. MedCenterDisplay's digital signage systems effectively communicate with patients and their families in healthcare facilities, providing engaging content while they wait for services. The company's offerings also encompass search engine optimization, reputation management, and video production, all aimed at empowering healthcare organizations to connect with their patients more effectively. Originally incorporated as AMS, LLC in 2007, MedCenterDisplay operates as a subsidiary of PatientPoint, LLC as of November 2016.

Diabetes Care Group, Inc. is a healthcare provider specializing in diabetes clinical care services for individuals with diabetes and metabolic diseases. Founded in 1986 and based in Jackson, Mississippi, the company integrates a multidisciplinary approach that includes medical management, patient education, behavioral modification, and individualized nutrition counseling. Their services are designed to enhance patient self-management and improve clinical outcomes while also aiming to reduce overall medical and social costs associated with diabetes. The company employs a team of experienced professionals, including board-certified physicians, registered nurse educators, registered dieticians, and medical assistants, all dedicated to delivering effective diabetes care. Diabetes Care Group has established a track record of significant improvements in health outcomes for patients facing the challenges of diabetes.

OnFocus Healthcare, originally established in 1985 as m21partners, transformed in 2008 into a provider of business execution software solutions for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance operational efficiency within healthcare organizations. Its flagship product, onFocus epm™, enables hospitals to improve patient care by streamlining processes, thereby ensuring that care is delivered more efficiently and cost-effectively. Through its software and advisory services, OnFocus Healthcare aims to elevate the performance and execution success of healthcare providers by at least 20%. The company's commitment is to support healthcare executives, managers, and staff in achieving their organizational goals and enhancing overall patient outcomes.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.

Industrial Ceramic Solutions, LLC is a manufacturer specializing in air pollution control equipment, particularly for industrial and diesel exhaust filter applications. Founded in 1997 and based in Oak Ridge, Tennessee, the company offers a range of products including diesel particulate filters, high-temperature exhaust filters, and devices for air, gas, odor, and smoke control. The founder, Richard Nixdorf, has over 40 years of experience in materials development, particularly in ceramics, metals, and polymers. His work led to innovations such as a silicon carbide fiber that can rapidly convert microwave energy to thermal energy, initially aimed at addressing regulatory requirements for diesel engine particulate filters. Although early attempts to utilize microwave energy for filter regeneration faced challenges, the company's products gained significant interest from major automotive suppliers. In 2007, a Fortune 100 company secured an exclusive license to manufacture the diesel particulate filter developed by ICS, although this agreement concluded in 2008 due to market conditions. Today, Industrial Ceramic Solutions continues to focus on advanced filtration technologies to meet evolving industrial needs.

Panopto, Inc. is a video software company that provides a comprehensive platform for video content management tailored for corporate and educational markets globally. Founded in 2007 and headquartered in Seattle, Washington, with additional offices in cities such as Pittsburgh, London, Sydney, and Hong Kong, Panopto specializes in creating searchable video libraries that preserve institutional knowledge. The platform encompasses a variety of functionalities, including video streaming, analytics, accessibility features, and live broadcasting capabilities. It supports users in recording and editing videos, facilitating employee training, onboarding, and live events for enterprises, as well as enhancing educational experiences through lecture capture and active learning. Panopto has established itself as a leader in video capture software and content management systems, recognized for its innovation and rapid growth within the industry.

OnFocus Healthcare, originally established in 1985 as m21partners, transformed in 2008 into a provider of business execution software solutions for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance operational efficiency within healthcare organizations. Its flagship product, onFocus epm™, enables hospitals to improve patient care by streamlining processes, thereby ensuring that care is delivered more efficiently and cost-effectively. Through its software and advisory services, OnFocus Healthcare aims to elevate the performance and execution success of healthcare providers by at least 20%. The company's commitment is to support healthcare executives, managers, and staff in achieving their organizational goals and enhancing overall patient outcomes.